Skip to content. | Skip to navigation

IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.



If you are interested in applying for access to the APGI Bioresource you can find out more information here. Upcoming APGI sponsored clinical trial projects are also listed here.

About APGI

The APGI is aiming to catalogue genomic abnormalities in pancreatic cancer using state of the art sequencing technologies. To do this, high quality well annotated biospecimens are required.

Read More…

The APGI BioResource

A key APGI priority is to continue to build capacity in translational research by acquiring biological material and clinico-pathological data for all types of pancreatic disease, which will provide an unparalleled base for ongoing studies. The APGI incorporates the NSW Pancreatic Cancer Network (2006-2010) and the Australian Familial Pancreatic Cancer Cohort (AFPaCC) (2011-2014).

Read More…

Current Research Studies

The APGI has multiple sub-studies investigating different aspects of pancreatic cancer diagnosis and treatment. We are always looking for more people to be involved in our research studies. Click to find out more about our current studies.

Read More…


The purpose of genome-wide survey of cancer cells is the identification of driver mutations which are key to the development of cancer at the cellular level.

Read More…

Studies We Have Supported

The APGI has provided coded clinical data and biological resources to many institutions and researchers to help further pancreatic cancer research worldwide.

Read More…


We are seeing great progress in pancreatic cancer research and the APGI and it's collaborators are at the heart of this.

Read More…